Roche notches fresh win amid crowd of immunotherapy cocktails – Reuters
|
Roche notches fresh win amid crowd of immunotherapy cocktails
Reuters ZURICH, Feb 6 (Reuters) – Roche’s Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker’s immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals … |
|
Roche notches fresh win amid crowd of immunotherapy cocktails
Reuters ZURICH, Feb 6 (Reuters) – Roche’s Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker’s immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals … |
Gizmodo |
DARPA Exec Warns Biohackers to ‘Think Deeply’ About Injecting Untested Treatments
Gizmodo On stage at Body Hacking Con this weekend, DARPA director of biological technologies Justin Sanchez ran through an impressive list of the sort of government projects that might interest people attending a conference about the integration of humans and … |
Genetic Literacy Project |
Viewpoint: US may be losing CRISPR race against China, but FDA regulations are worth it
Genetic Literacy Project [H]ow did China edge out the United States to become the first to use CRISPR in humans? American researchers were, after all, the ones who discovered the techniques’ ability to tweak and alter DNA. … China is already so far along, and in some … |
|
Incurable arthritic knees? Gene therapy offers new hope
Genetic Literacy Project This provides assurances against overdosing and greatly reduces the risk of adverse effects,” he said. Evans’ group is using AAV which, unlike other vectors, can deliver its cargo straight to the affected chondrocytes in an inflamed joint – “in situ … |